Company profile: Herborium
1.1 - Company Overview
Company description
- Provider of botanical therapeutics that develops, licenses, and markets proprietary botanical-based medicinal products. Offerings include AcnEase, a herbal acne and rosacea treatment; the Virtual Institute for Natural and Complementary Medicine, an educational platform for integrative medicine; the Kamasutra Spirits product line; and Herborium Botanical Therapeutics addressing dermatological needs and sexual disorders.
Products and services
- Herborium Botanical Therapeutics: Proprietary botanical-based medicinal products engineered to target various health concerns, including dermatological needs and sexual disorders, supplying plant-derived therapies
- AcnEase: Herbal-formulated botanical acne treatment addressing acne and rosacea symptoms using plant-based ingredients, delivering targeted symptom relief for acne and rosacea conditions
- Virtual Institute for Natural and Complementary Medicine (VINCM): Professional-focused educational platform for healthcare professionals and consumers enhancing understanding and application of integrative medicine
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Herborium
Purdue Pharma
HQ: United States
Website
- Description: Provider of medications and consumer health products for healthcare professionals, patients, consumers, and caregivers; develops, manufactures, and markets prescription opioid analgesics for pain management and over-the-counter medications including laxatives, antiseptics, and dietary supplements; offers public health initiatives; and conducts research and development of medications for cancer and central nervous system disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Purdue Pharma company profile →
Aurex Labs
HQ: United States
Website
- Description: Provider of fully integrated pharmaceutical development and manufacturing services, including high-quality clinical supplies, tablets, and soft gelatin capsules. Maintains capabilities for manufacturing various dosage forms and quality control.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aurex Labs company profile →
Eagle Pharmaceuticals
HQ: United States
Website
- Description: Provider of injectable pharmaceuticals for critical care and oncology, including PEMFEXY (pemetrexed) for nonsquamous NSCLC and malignant pleural mesothelioma; BARHEMSYS (amisulpride) for prevention and treatment of postoperative nausea and vomiting; BYFAVO (remimazolam) for procedural sedation; RYANODEX (dantrolene) for malignant hyperthermia; BELRAPZO and BENDEKA (bendamustine) for CLL and indolent B-cell NHL.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Eagle Pharmaceuticals company profile →
DiaMedica Therapeutics
HQ: United States
Website
- Description: Provider of biopharmaceutical R&D focused on treatments for stroke, developing DM199, a recombinant human tissue kallikrein-1 (KLK1) intended to treat acute ischemic stroke and cardio-renal diseases by restoring KLK1 levels, and conducting the ReMEDy2 adaptive, randomized, double-blind, placebo-controlled trial to study DM199’s efficacy and safety in acute ischemic stroke.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DiaMedica Therapeutics company profile →
The Medicines Company
HQ: United States
Website
- Description: Provider of innovative, cost-effective medicines to the worldwide hospital marketplace, focused on advancing treatment of critical care patients. Markets Angiomax(R) (bivalirudin) in the United States and other countries for use in patients undergoing coronary angioplasty, and Cleviprex(R).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full The Medicines Company company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Herborium
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Herborium
2.2 - Growth funds investing in similar companies to Herborium
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Herborium
4.2 - Public trading comparable groups for Herborium
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →